This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: The Asan Foundation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Bong Choel Kim
Introduction
Bong Choel Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in cancer treatment. His innovative approach focuses on enhancing the effectiveness of therapies through targeted methods.
Latest Patents
One of his key patents is titled "Method for determining sensitivity to simultaneous inhibitor against PARP and Tankyrase." This invention relates to a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. The patent aims to maximize the treatment effect for colorectal cancer by identifying patients who are sensitive to this combined inhibitor.
Career Highlights
Bong Choel Kim has worked with prominent organizations such as the Asan Foundation and Onconic Therapeutics Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Dong Hoon Jin and Seung Woo Hong. Their collective efforts have advanced the understanding of cancer therapies and improved patient outcomes.
Conclusion
Bong Choel Kim's innovative work in developing methods for cancer treatment exemplifies the impact of targeted therapies in modern medicine. His contributions continue to influence the field and offer hope for improved patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile